Dehydrocostus lactone inhibits NFATc1 via regulation of IKK, JNK, and Nrf2, thereby attenuating osteoclastogenesis
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Excessive and hyperactive osteoclast activity causes bone diseases such as osteoporosis and periodontitis. Thus, the regulation of osteoclast differentiation has clinical implications. We recently reported that dehydrocostus lactone (DL) inhibits osteoclast differentiation by regulating a nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), but the underlying mechanism remains to be elucidated. Here we demonstrated that DL inhibits NFATc1 by regulating nuclear factor-B (NF- B), activator protein-1 (AP-1), and nuclear factor-erythroid 2- related factor 2 (Nrf2). DL attenuated IB phosphorylation and p65 nuclear translocation as well as decreased the expression of NF-B target genes and c-Fos. It also inhibited c-Jun N-terminal kinase (JNK) but not p38 or extracellular signalregulated kinase. The reporter assay revealed that DL inhibits NF-B and AP-1 activation. In addition, DL reduced reactive oxygen species either by scavenging them or by activating Nrf2. The DL inhibition of NFATc1 expression and osteoclast differentiation was less effective in Nrf2-deficient cells. Collectively, these results suggest that DL regulates NFATc1 by inhibiting NF-B and AP-1 via down-regulation of IB kinase and JNK as well as by activating Nrf2, and thereby attenuates osteoclast differentiation.
Abstract
Excessive and hyperactive osteoclast activity causes bone diseases such as osteoporosis and periodontitis. Thus, the regulation of osteoclast differentiation has clinical implications. We recently reported that dehydrocostus lactone (DL) inhibits osteoclast differentiation by regulating a nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), but the underlying mechanism remains to be elucidated. Here we demonstrated that DL inhibits NFATc1 by regulating nuclear factor-B (NF- B), activator protein-1 (AP-1), and nuclear factor-erythroid 2- related factor 2 (Nrf2). DL attenuated IB phosphorylation and p65 nuclear translocation as well as decreased the expression of NF-B target genes and c-Fos. It also inhibited c-Jun N-terminal kinase (JNK) but not p38 or extracellular signalregulated kinase. The reporter assay revealed that DL inhibits NF-B and AP-1 activation. In addition, DL reduced reactive oxygen species either by scavenging them or by activating Nrf2. The DL inhibition of NFATc1 expression and osteoclast differentiation was less effective in Nrf2-deficient cells. Collectively, these results suggest that DL regulates NFATc1 by inhibiting NF-B and AP-1 via down-regulation of IB kinase and JNK as well as by activating Nrf2, and thereby attenuates osteoclast differentiation.
참고문헌 (29)
- Manolagas SC, "Birth and death of bone cells : basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis", Endocr Rev, 21, pp.115~137 (2000)
- Rodan GA, "Therapeutic approaches to bone diseases", Science, 289, pp.1508~1514 (2000)
- Ross FP, "alphavbeta3 and macrophage colony-stimulating factor : partners in osteoclast biology", Immunol Rev, 208, pp.88~105 (2005)
- Theill LE, "RANK-L and RANK : T cells, bone loss, and mammalian evolution", Annu Rev Immunol, 20, pp.795~823 (2002)
- Asagiri M, "The molecular understanding of osteoclast differentiation", Bone, 40, pp.251~264 (2007)
- Grigoriadis AE, "c-Fos : a key regulator of osteoclast-macrophage lineage determination and bone remodeling", Science, 266, pp.443~448 (1994)
- Lee NK, "A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation", Blood, 106, pp.852~859 (2005)
- Garrett IR, "Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo", J Clin Invest, 85, pp.632~639 (1990)
- Bax BE, "Stimulation of osteoclastic bone resorption by hydrogen peroxide", Biochem Biophys Res Commun, 183, pp.1153~1158 (1992)
- Lean JM, "A crucial role for thiol antioxidants in estrogen-deficiency bone loss", J Clin Invest, 112, pp.915~923 (2003)
- Chen JR, "Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats", J Pharmacol Exp Ther, 336, pp.734~742 (2011)
- Hong S, "TRP14 inhibits osteoclast differentiation via its catalytic activity", Mol Cell Biol, 34, pp.3515~3524 (2014)
- Hyeon S, "Nrf2deficiency induces oxidative stress and promotes RANKLinduced osteoclast differentiation", Free Radic Biol Med, 65, pp.789~799 (2013)
- Jeong GS, "The alphamethylene-gamma-butyrolactone moiety in dehydrocostus lactone is responsible for cytoprotective heme oxygenase-1expression through activation of the nuclear factor E2-related factor 2 in HepG2 cells", Eur J Pharmacol, 565, pp.37~44 (2007)
- Choi EM, "Protective effects of dehydrocostus lactone against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1cells", Toxicol In Vitro, 23, pp.862~867 (2009)
- Lee HI, "Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome function", FASEB J, 33, pp.9685~9694 (2019)
- Wang J, "Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-kappaB", COX-2 signaling pathway by targeting IKKbeta, 2017, pp.7, 1270~1284
- Hazzalin CA, "MAPK-regulated transcription: a continuously variable gene switch?", Nat Rev Mol Cell Biol, 3, pp.30~40 (2002)
- Tu YC, "Regulation of c-Fos gene expression by NF-kappaB : a p65 homodimer binding site in mouse embryonic fibroblasts but not human HEK293 cells", PLoS One, 8, pp.e84062~ (2013)
- Fujioka S, "NF-kappaB and AP-1 connection : mechanism of NF-kappaB-dependent regulation of AP-1 activity", Mol Cell Biol, 24, pp.7806~7819 (2004)
- Whitmarsh AJ, "Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors", Mol Cell Biol, 17, pp.2360~2371 (1997)
- Gloire G, "NF-kappaB activation by reactive oxygen species : fifteen years later", Biochem Pharmacol, 72, pp.1493~1505 (2006)
- Jung Y, "Dynein light chain LC8 negatively regulates NF-kappaB through the redox-dependent interaction with IkappaBalpha", J Biol Chem, 283, pp.23863~23871 (2008)
- Kamata H, "Reactive oxygen species promote TNFalphainduced death and sustained JNK activation by inhibiting MAP kinase phosphatases", Cell, 120, pp.649~661 (2005)
- Hong SE, "Euphorbia factor L1inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast", Free Radic Biol Med, 112, pp.191~199 (2017)
- Chang TS, "Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine", J Biol Chem, 279, pp.50994~51001 (2004)
- Kim H, "Dynein light chain LC8 inhibits osteoclast differentiation and prevents bone loss in mice", J Immunol, 190, pp.1312~1318 (2013)
- 진수현, "Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility", BMB Reports, 51(7), pp.356~361 (2018), 생화학분자생물학회
- Lee J, "Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signaling", FASEB J, 33, pp.2026~2036 (2019)